Cintas Operating Cash Flow increased by 17.0% to $621.47M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 0.2%, from $620.50M to $621.47M. Over 4 years (FY 2021 to FY 2025), Operating Cash Flow shows an upward trend with a 12.3% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
An increase indicates strong operational efficiency and cash generation, while a decrease may signal operational challenges or issues with working capital management.
This metric represents the total cash generated or consumed by a company's core business operations during a specific pe...
Standard across all industries; peers in the medical device and diagnostics sector typically maintain high conversion ratios of net income to operating cash flow.
net_cash_from_operating| Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $455.93M | $262.14M | $331.64M | $393.27M | $550.57M | $298.16M | $320.99M | $425.04M | $542.04M | $336.95M | $392.69M | $657.11M | $681.76M | $460.36M | $444.73M | $620.50M | $640.32M | $414.48M | $531.22M | $621.47M |
| QoQ Change | — | -42.5% | +26.5% | +18.6% | +40.0% | -45.8% | +7.7% | +32.4% | +27.5% | -37.8% | +16.5% | +67.3% | +3.8% | -32.5% | -3.4% | +39.5% | +3.2% | -35.3% | +28.2% | +17.0% |
| YoY Change | — | — | — | — | +20.8% | +13.7% | -3.2% | +8.1% | -1.5% | +13.0% | +22.3% | +54.6% | +25.8% | +36.6% | +13.3% | -5.6% | -6.1% | -10.0% | +19.4% | +0.2% |